3.8 Article

Analysis of phenethylamines and tryptamines in designer drugs using gas chromatography-mass spectrometry

Journal

JOURNAL OF HEALTH SCIENCE
Volume 54, Issue 1, Pages 89-96

Publisher

PHARMACEUTICAL SOC JAPAN
DOI: 10.1248/jhs.54.89

Keywords

designer drug; hallucinogen; phenethylamine; tryptamine; nuclear magnetic resonance; quantitative analysis

Categories

Ask authors/readers for more resources

We developed a method for determining the following ten psychedelic phenethylamines and tryptamines by gas chromatography-mass spectrometry (GC-MS). The phenethylamines examined were 3,4,5-trimethoxyamphetamine (TMA), 2,4,5-trimethoxyamphetamine (TMA-2), 4-bromo-2,5-dimethoxyphenethylamine (2C-B), 4-iodo-2,5-dimethoxyphenethylamine (2C-I), 2,5-dimethoxy-4-ethylthiophenethylamine (2CT-2), and 2,5-dimethoxy-4-propylthiophenethylamine (2CT-7). The tryptamines examined were 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), alpha-methyltryptamine (AMT), Nisopropyl-5-methoxy-N-methyltryptamine (5-MeO-MIPT), and N,N-diisopropyl-5-methoxytryptamine (5-MeO-DIPT). As the reference standards, five compounds were newly synthesized, and five were purified from the products. These were all structurally ascertained by GG-MS and nuclear magnetic resonance (NMR) spectroscopy. Between April 2005 and March 2007, 8 compounds analyzed in this study were found in 100 out of the 178 products which were examined.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available